Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Infection ; 52(2): 429-437, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-37697224

RESUMEN

INTRODUCTION: Carbapenem-resistant Klebsiella pneumoniae (CRKP) infections commonly cause hospital-acquired infections. The study aimed to compare the outcomes of CRKP infections between patients receiving ceftazidime avibactam +/- aztreonam and polymyxins in a hospital setting with a high prevalence of New Delhi Metallo Beta Lactamase production. METHODS: We conducted a retrospective cohort study from January 2020 to September 2022 in critically ill adult patients admitted to a non-COVID-19 medical intensive care unit with CRKP infection. The patients were followed up for a total of 30 days or death, whichever was later. RESULTS: Of a total of 106 patients included in the study, 65 patients received polymyxins and 41 patients received ceftazidime-avibactam +/- aztreonam. Higher 30-day mortality was noted in the polymyxin group (56.9% vs. 29.2%, P = 0.005). The mean time to event (mortality) in ceftazidime-avibactam +/- aztreonam was 23.9 + 1.5 days which was significantly higher compared to polymyxins (17.9 + 1.2 days, p = 0.006). On Cox regression analysis, after adjusting for the covariates, the hazard ratio for time to event with the use of polymyxin was 2.02 (95% CI: 1.03-3.9). CONCLUSION: Ceftazidime-avibactam + aztreonam is possibly associated with better clinical outcomes in patients infected with CRKP.


Asunto(s)
Compuestos de Azabiciclo , Infección Hospitalaria , Infecciones por Klebsiella , Adulto , Humanos , Ceftazidima/uso terapéutico , Aztreonam/uso terapéutico , Antibacterianos/uso terapéutico , Klebsiella pneumoniae , Polimixinas/uso terapéutico , Infección Hospitalaria/tratamiento farmacológico , Estudios Retrospectivos , Combinación de Medicamentos , beta-Lactamasas , Carbapenémicos , Pruebas de Sensibilidad Microbiana , Infecciones por Klebsiella/tratamiento farmacológico
2.
J Mycol Med ; 33(3): 101406, 2023 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-37229913

RESUMEN

Cryptococcal meningitis is a life-threatening infection commonly seen in patients with advanced HIV infection and solid organ transplant recipients. We report a case of cryptococcal meningitis with immune reconstitution syndrome (IRIS) who presented to us with a headache and complete loss of vision in the left eye. He was managed with antifungals and a short course of steroids, and he regained vision completely. In the hospital, he developed complications including tacrolimus toxicity, fluconazole-induced QT prolongation, and flucytosine-induced thrombocytopenia. Our case demonstrates the importance of a multidisciplinary approach in the management of complex cases like cryptococcal meningitis in solid organ transplant recipients.


Asunto(s)
Infecciones por VIH , Síndrome Inflamatorio de Reconstitución Inmune , Meningitis Criptocócica , Trasplante de Órganos , Masculino , Humanos , Meningitis Criptocócica/complicaciones , Meningitis Criptocócica/tratamiento farmacológico , Infecciones por VIH/complicaciones , Síndrome Inflamatorio de Reconstitución Inmune/complicaciones , Síndrome Inflamatorio de Reconstitución Inmune/tratamiento farmacológico , Antifúngicos/efectos adversos , Corticoesteroides , Ceguera , Trasplante de Órganos/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA